Long-Term Mental Health Outcomes in Prostate Cancer Survivors and Their Partners
前列腺癌幸存者及其伴侣的长期心理健康结果
基本信息
- 批准号:10908089
- 负责人:
- 金额:$ 41.81万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-06-21 至 2026-03-31
- 项目状态:未结题
- 来源:
- 关键词:AddressAnxietyBirthCancer PatientCancer SurvivorshipCaringCause of DeathCessation of lifeCharacteristicsClinicalCountryDataDiagnosisDiseaseDistressDrug Use DisorderEarly InterventionEducationEducational workshopEthnic OriginHealthHospitalsIncidenceIncomeIndividualInpatientsInterventionKnowledgeLong-Term CareLongitudinal StudiesMajor Depressive DisorderMalignant NeoplasmsMalignant neoplasm of prostateMarital StatusMental DepressionMental HealthMental disordersMilitary PersonnelModelingOperative Surgical ProceduresOutcomeOutpatientsPatientsPersonsPopulationPredispositionPrimary CareProstate Cancer therapyPublic HealthQuality of lifeRaceRadiationRegistriesRelative RisksResearchRiskRisk AssessmentSample SizeSelf CareSexual DysfunctionSpousesStressSubgroupSuicideSuicide attemptSwedenTestingTimeUnited States National Institutes of HealthUrinary IncontinenceVulnerable Populationsalcohol use disordercancer diagnosiscancer survivalcancer therapycaregivingcohortcostcost efficientfollow-uphigh riskimprovedinnovationmedical specialtiesmenmortalitypopulation basedprematurepreventprostate cancer survivorspsychosocialside effectstress resiliencetumor
项目摘要
Prostate cancer (PC) is the most commonly diagnosed cancer among men in the US and in most countries
worldwide. Over 3.6 million US men are currently living with PC, and this number is expected to increase to >5
million by 2030. Approximately 90% of PC cases are diagnosed at a local or regional stage, when the 5-year
survival is >99%. Consequently, most men with PC survive >15-20 years after diagnosis. However, PC
diagnosis and treatment can be devastating for men and their partners, and may increase risks of mental
illness. Importantly, mental disorders are treatable, and early intervention could reduce suffering, improve
quality of life, and prevent premature death. Despite the high public health burden of mental disorders, they
are severely understudied compared with somatic outcomes of PC. A comprehensive understanding of long-
term mental health sequelae is critically needed to improve care and outcomes for PC survivors and their
partners. The few prior studies have had important limitations, including limited follow-up times and sample
sizes, and ascertainment of mental disorders using only hospital data, which captures only the most severe
cases. No large-scale studies have included partners. We will address these limitations by conducting the first
comprehensive long-term study of mental health outcomes in PC survivors and partners in a national cohort (N
>4 M) using highly complete data from primary care, specialty outpatient, and inpatient settings. We
hypothesize that PC survivors and their partners have increased risks of major mental disorders and suicide.
To test this hypothesis, we will examine these outcomes in 210,432 men diagnosed with PC in Sweden in
1987-2018 and their 163,085 partners, compared with 2.1 M men without PC and their 1.6 M partners, followed
for up to 34 years through 2020. Sweden is an ideal setting because individual-level data an PC diagnoses,
treatment, and mental health outcomes are available for the entire population with over 3 decades of follow-up,
and the incidence and treatment of PC and common mental disorders are comparable to the US. This
proposal addresses key priorities identified by the 2019 NCI workshop on "Evidence Gaps in Cancer
Survivorship Care". Our specific aims are to identify: (1) long-term risks of 4 mental disorders (major
depression, anxiety, alcohol and drug use disorders) and suicide in PC survivors; (2) high-risk subgroups who
may benefit most from interventions; (3) whether mental disorders are associated with higher PC-specific
mortality; and (4) long-term risks of mental disorders and suicide in partners of PC survivors. The proposed
research is significant because millions of men are surviving with PC, and their mental health sequelae may
have substantial impacts that are understudied and preventable. It is innovative because it will provide the first
long-term assessment in a national cohort of PC survivors and partners by integrating unparalleled individual-
level data for >4 M people. The results will identify the long-term mental health outcomes in PC survivors, their
partners, and high-risk subgroups, and guide early interventions to improve their long-term health.
前列腺癌(PC)是美国和大多数国家男性中最常见的癌症
国际吧超过360万美国男性目前与PC生活在一起,预计这一数字将增加到5
到2030年,亿。大约90%的PC病例是在当地或区域阶段诊断出来的,此时5年
存活率> 99%。因此,大多数PC患者在诊断后存活>15-20年。然而,PC
诊断和治疗对男性及其伴侣来说可能是毁灭性的,并可能增加精神疾病的风险。
病重要的是,精神障碍是可以治疗的,早期干预可以减少痛苦,改善
提高生活质量,防止过早死亡。尽管精神障碍的公共卫生负担很高,
与PC的躯体结局相比,全面了解长期以来
长期心理健康后遗症是迫切需要改善护理和PC幸存者及其
伙伴少数先前的研究有重要的局限性,包括有限的随访时间和样本
规模,并确定精神障碍只使用医院的数据,其中只捕获最严重的
例没有大规模的研究包括合作伙伴。我们将通过进行第一次
在一个国家队列中对PC幸存者及其伴侣的心理健康结果进行了一项全面的长期研究(N
>4 M)使用来自初级保健、专科门诊和住院设置的高度完整的数据。我们
假设PC幸存者和他们的伴侣患主要精神障碍和自杀的风险增加。
为了验证这一假设,我们将在2009年对瑞典210,432名被诊断为PC的男性进行研究。
1987-2018年,他们的163,085名伴侣,相比之下,210万没有PC的男性和他们的160万伴侣,
到2020年,长达34年。瑞典是一个理想的环境,因为个人电脑诊断的个人数据,
治疗和心理健康结果可用于整个人群,随访时间超过30年,
PC和常见精神障碍的发病率和治疗与美国相当。这
该提案解决了2019年NCI研讨会确定的关键优先事项“癌症的证据差距”
幸存者护理”。我们的具体目标是确定:(1)4种精神障碍的长期风险(主要
抑郁症,焦虑症,酒精和药物使用障碍)和自杀的PC幸存者;(2)高危亚组,
可能从干预中获益最多;(3)精神障碍是否与较高的PC特异性相关
死亡率;(4)PC幸存者伴侣的精神障碍和自杀的长期风险。拟议
这项研究意义重大,因为数百万男性在PC中生存,他们的心理健康后遗症可能
有着未被充分研究和可预防的重大影响。它是创新的,因为它将提供第一个
通过整合无与伦比的个人信息,
>4 M人的水平数据。结果将确定PC幸存者的长期心理健康结果,
这一方案将为艾滋病毒/艾滋病感染者、艾滋病伙伴和高危亚组提供指导,并指导早期干预措施,以改善他们的长期健康。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Casey Crump其他文献
Casey Crump的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Casey Crump', 18)}}的其他基金
Mental Health Outcomes in Alzheimer's Disease Patients and Their Partners
阿尔茨海默病患者及其伴侣的心理健康结果
- 批准号:
10726776 - 财政年份:2023
- 资助金额:
$ 41.81万 - 项目类别:
Long-Term Mental Health Outcomes in Prostate Cancer Survivors and Their Partners
前列腺癌幸存者及其伴侣的长期心理健康结果
- 批准号:
10416343 - 财政年份:2022
- 资助金额:
$ 41.81万 - 项目类别:
Long-Term Mental Health Outcomes in Prostate Cancer Survivors and Their Partners
前列腺癌幸存者及其伴侣的长期心理健康结果
- 批准号:
10650842 - 财政年份:2022
- 资助金额:
$ 41.81万 - 项目类别:
Preterm birth and long-term risk of cardiovascular disease in mothers and offspring
母亲和后代的早产和心血管疾病的长期风险
- 批准号:
9759973 - 财政年份:2018
- 资助金额:
$ 41.81万 - 项目类别:
Adverse pregnancy outcomes and long-term risk of cardiovascular disease in women
女性不良妊娠结局和心血管疾病的长期风险
- 批准号:
10610456 - 财政年份:2018
- 资助金额:
$ 41.81万 - 项目类别:
Preterm birth and long-term risk of cardiovascular disease in mothers and offspring
母亲和后代的早产和心血管疾病的长期风险
- 批准号:
10155552 - 财政年份:2018
- 资助金额:
$ 41.81万 - 项目类别:
Preterm birth and long-term risk of cardiovascular disease in mothers and offspring
母亲和后代的早产和心血管疾病的长期风险
- 批准号:
9592417 - 财政年份:2018
- 资助金额:
$ 41.81万 - 项目类别:
Adverse pregnancy outcomes and long-term risk of cardiovascular disease in women
女性不良妊娠结局和心血管疾病的长期风险
- 批准号:
10446071 - 财政年份:2018
- 资助金额:
$ 41.81万 - 项目类别:
Preterm birth and long-term risk of cardiovascular disease in mothers and offspring
母亲和后代的早产和心血管疾病的长期风险
- 批准号:
9926123 - 财政年份:2018
- 资助金额:
$ 41.81万 - 项目类别:
Discovering and Characterizing Novel Pregnancy-Associated Cancers
发现和表征新的与妊娠相关的癌症
- 批准号:
9330818 - 财政年份:2016
- 资助金额:
$ 41.81万 - 项目类别:
相似海外基金
Atomic Anxiety in the New Nuclear Age: How Can Arms Control and Disarmament Reduce the Risk of Nuclear War?
新核时代的原子焦虑:军控与裁军如何降低核战争风险?
- 批准号:
MR/X034690/1 - 财政年份:2024
- 资助金额:
$ 41.81万 - 项目类别:
Fellowship
Clinitouch-360: A digital health platform enabling robust end-to-end care of patients in Primary Care with depression and anxiety
Clinitouch-360:数字健康平台,可为初级保健中的抑郁和焦虑患者提供强大的端到端护理
- 批准号:
10098274 - 财政年份:2024
- 资助金额:
$ 41.81万 - 项目类别:
Collaborative R&D
Mental Health and Occupational Functioning in Nurses: An investigation of anxiety sensitivity and factors affecting future use of an mHealth intervention
护士的心理健康和职业功能:焦虑敏感性和影响未来使用移动健康干预措施的因素的调查
- 批准号:
10826673 - 财政年份:2024
- 资助金额:
$ 41.81万 - 项目类别:
Visual analysis system to detect and predict the signs of anxiety in healthcare
用于检测和预测医疗保健中焦虑迹象的视觉分析系统
- 批准号:
2902083 - 财政年份:2024
- 资助金额:
$ 41.81万 - 项目类别:
Studentship
Using generative AI combined with immersive technology to treat anxiety disorders
利用生成式人工智能结合沉浸式技术治疗焦虑症
- 批准号:
10109165 - 财政年份:2024
- 资助金额:
$ 41.81万 - 项目类别:
Launchpad
Healthy Young Minds: co-producing a nature-based intervention with rural High School students to promote mental well-being and reduce anxiety
健康的年轻心灵:与农村高中生共同开展基于自然的干预措施,以促进心理健康并减少焦虑
- 批准号:
MR/Z503599/1 - 财政年份:2024
- 资助金额:
$ 41.81万 - 项目类别:
Research Grant
"Flashforward" imagery and anxiety in young adults: Risk mechanisms and intervention development
年轻人的“闪现”意象和焦虑:风险机制和干预措施的发展
- 批准号:
MR/Y009460/1 - 财政年份:2024
- 资助金额:
$ 41.81万 - 项目类别:
Fellowship
How parents manage climate anxiety: coping and hoping for the whole family
父母如何应对气候焦虑:全家人的应对和希望
- 批准号:
DP230101928 - 财政年份:2024
- 资助金额:
$ 41.81万 - 项目类别:
Discovery Projects
An innovative biofeedback enhanced adaptive extended reality (XR) device to reduce perinatal pain and anxiety during and after childbirth
一种创新的生物反馈增强型自适应扩展现实 (XR) 设备,可减少分娩期间和分娩后的围产期疼痛和焦虑
- 批准号:
10097862 - 财政年份:2024
- 资助金额:
$ 41.81万 - 项目类别:
Collaborative R&D
Digital cognitive-behavior therapy for anxiety and depressive disorders: Building an impactful research project from international partnerships and knowledge exchange in primary care
针对焦虑和抑郁症的数字认知行为疗法:通过初级保健领域的国际合作和知识交流建立一个有影响力的研究项目
- 批准号:
480808 - 财政年份:2023
- 资助金额:
$ 41.81万 - 项目类别:
Miscellaneous Programs














{{item.name}}会员




